[Epidermolysis bullosa atrophicans generalisata mitis].
Since the first description in 1976, epidermolysis bullosa atrophicans generalisata mitis has been recognized as a seperate entity, based on clinical and electron microscopical findings, and has been differentiated from epidermolysis atrophicans generalisata gravis Herlitz. Our own observations on a patient are presented by clinical documentation.
D001323:Autoantibodies / Q000032:analysis; D002648:Child; D003094:Collagen / Q000276:immunology; D003622:Dapsone / Q000627:therapeutic use; D004820:Epidermolysis Bullosa / Q000188:drug therapy / Q000276:immunology / Q000473:pathology*; D005260:Female; D006801:Humans; D012867:Skin / Q000473:pathology
D001323:Autoantibodies; D003622:Dapsone; D003094:Collagen
Epidermolysis bullosa atrophicans generalisata mitis.